Intensity Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Intensity Therapeutics generated cash of -$7,205,000, which is less than the previous year. Cash used in financing activities reached the amount of $20,472,000 last year. Net change in cash is therefore $7,244,000.
Cash Flow
| 2019 | -4.41M | 1.69M | 3.85M |
|---|---|---|---|
| 2020 | -5.37M | 4.56M | 6.29M |
| 2021 | -6.82M | 0 | 2.05M |
| 2022 | -5.47M | 0 | 2.25M |
| 2023 | -7.20M | -6.02M | 20.47M |
INTS Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 1.31M | 4.53M | 9.31M | 3.82M | 2.68M |
Operating activities | |||||
Net income | -10.53M | -7.58M | -7.89M | -6.03M | -5.37M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 0 | 179.03K | 0 | 0 | 0 |
Stock-based compensation expense | 1.39M | 1.16M | 719.82K | 555.48K | 561.37K |
| Deferred income tax benefit | 1.39M | 1.16M | 719.82K | 555.48K | 561.37K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 16.76K | 0 | 0 |
Inventories | 0 | 0 | -16.76K | 0 | 0 |
Accounts payable | 1.63M | 430.66K | -50.19K | -171.25K | 202.55K |
Cash generated by operating activities | -7.20M | -5.47M | -6.82M | -5.37M | -4.41M |
Investing activities | |||||
Purchases Of Investments | -15.05M | 0 | 0 | -10.89M | -7.07M |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -6.02M | 0 | 0 | 4.56M | 1.69M |
Financing activities | |||||
Common Stock Issued | 22.42M | 0 | 0 | 6.26M | 3.85M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 230K | 2.25M | -2M | 0 | 0 |
Cash used in financing activities | 20.47M | 2.25M | 2.05M | 6.29M | 3.85M |
Net Change In Cash | 7.24M | -3.22M | -4.77M | 5.48M | 1.13M |
Cash at end of period | 8.55M | 1.31M | 4.53M | 9.31M | 3.82M |
| Data source |